Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Renato Lopes Hurtado"'
Publikováno v:
Cadernos de Saúde Pública, Vol 30, Iss 4, Pp 891-895 (2014)
O problema de falsificação de medicamentos aumenta a cada dia, acentuado pela globalização e vantagem financeira inerente a essa atividade. Diversos tipos de medicamentos têm sido alvo de falsificações, tornando-se um grave problema de saúde
Externí odkaz:
https://doaj.org/article/a7225155ead4424ab780063a1fb5c2e4
Autor:
Renato Lopes Hurtado, Sérgia Maria Starling Magalhães, Andréia Queiroz Ribeiro, Micheline Rosa da Silveira
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 46, Iss 2, Pp 289-296 (2010)
Selecting the most suitable drug for the treatment of depression has clinical and economic implications, since both safety and cost of antidepressants (AD) vary among therapeutic subgroups. This study aimed to evaluate the prescription of antidepress
Externí odkaz:
https://doaj.org/article/231c4858a6c64c1c9cd4d4acca1d0f91
Autor:
Renato Lopes Hurtado
Publikováno v:
Biblioteca Digital de Teses e Dissertações da UFMGUniversidade Federal de Minas GeraisUFMG.
The depression is a problem of public world-wide health, when thought the 4th biggest prebrave problem in the world. It causes serious incompetence and negative influence in the lifes capacity of the patients, of his relatives and of the society as a
Externí odkaz:
http://hdl.handle.net/1843/VSJE-7P6NSQ
Publikováno v:
Cadernos de saude publica. 30(4)
The problem of counterfeit medicines is increasing rapidly, aggravated by globalization and the lure of profit from this illegal activity. Various types of drugs have been counterfeited, posing a serious public health and safety problem. The current
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::57723d96b7c7d4b9d96965120fd4627d
https://pubmed.ncbi.nlm.nih.gov/24896066
https://pubmed.ncbi.nlm.nih.gov/24896066
Autor:
Andréia Queiroz Ribeiro, Sérgia Maria Starling Magalhães, Renato Lopes Hurtado, Micheline Rosa Silveira
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences; Vol. 46 No. 2 (2010); 289-296
Brazilian Journal of Pharmaceutical Sciences; Vol. 46 Núm. 2 (2010); 289-296
Brazilian Journal of Pharmaceutical Sciences; v. 46 n. 2 (2010); 289-296
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 46, Iss 2, Pp 289-296 (2010)
Brazilian Journal of Pharmaceutical Sciences, Volume: 46, Issue: 2, Pages: 289-296, Published: JUN 2010
Brazilian Journal of Pharmaceutical Sciences; Vol. 46 Núm. 2 (2010); 289-296
Brazilian Journal of Pharmaceutical Sciences; v. 46 n. 2 (2010); 289-296
Brazilian Journal of Pharmaceutical Sciences
Universidade de São Paulo (USP)
instacron:USP
Brazilian Journal of Pharmaceutical Sciences, Vol 46, Iss 2, Pp 289-296 (2010)
Brazilian Journal of Pharmaceutical Sciences, Volume: 46, Issue: 2, Pages: 289-296, Published: JUN 2010
Selecting the most suitable drug for the treatment of depression has clinical and economic implications, since both safety and cost of antidepressants (AD) vary among therapeutic subgroups. This study aimed to evaluate the prescription of antidepress
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2fb3fc372558eec94a17787fa30ec773
https://www.revistas.usp.br/bjps/article/view/10782
https://www.revistas.usp.br/bjps/article/view/10782
